OCULOcular Therapeutix, Inc.
$6.50-47% 1Y
$6.50
$6.2952 weeks$16.11
Is the price fair?
What OCUL's price assumes
Ocular Therapeutix, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 27.4× revenue.
27.4
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 2.74
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 17.3
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 2.74
- EV / EBIToperating margin −603%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 17.3
- Market capitalisation219.6 million shares, counted Jul 31, 2026
- $1.43B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks